Chapter 1 Incidence of End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.

Slides:



Advertisements
Similar presentations
Acute Glomerulonephritis
Advertisements

Chapter 7: Pediatric ESRD 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
© ANZDATA Registry CANCER CHAPTER CHAPTER 10. © ANZDATA Registry CharacteristicMyelomaNon-Myeloma n%n% Total (%)807153,37199 Country of residence Australia ,25683.
Pathology of the Kidney and Its Collecting System
The Kidneys Major Topics for Discussion Review of anatomy and physiology Congenital anomalies Glomerular diseases Vascular diseases Kidney stones Neoplasia.
Glomerular Diseases Dr. Atapour Differential diagnosis and evaluation of glomerular disease.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
Nephritic Syndromes Dr. Raid Jastania.
Renal Pathology. Introduction: 150gm: each kidney 1700 liters of blood filtered  180 L of G. filtrate  1.5 L of urine / day. Kidney is a retro-peritoneal.
Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the NSW Southern Area.
End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand ANZDATA Registry Annual Report Chapter 12.
NEW PATIENTS COMMENCING TREATMENTS IN 2010 CHAPTER 2.
ANZDATA Registry Annual Report 2013 NEW PATIENTS CHAPTER 2.
Acute Glomerulonephritis. Definition and Incidence Acute Glomerulonephritis (acute nephritic syndrome) is the sudden onset of: – Haematuria (macroscopic/microscopic)
Allocation of deceased donor kidneys Phil Clayton NSW Renal Group 14 June 2012.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Renal Pathology. Introduction Glomerular diseases Tubular and interstitial diseases Diseases involving blood vessels Cystic diseases Tumors Renal Pathology.
Urinary System Tutorial Glomerulonephritis
Copyright © 2015 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 25 Disorders of Renal Function.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN Annual Report—35th Edition ANZDATA Registry Annual Report.
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
© ANZDATA Registry PEADIATRIC CHAPTER CHAPTER 11.
© ANZDATA Registry TRANSPLANT WAITING LIST CHAPTER 7.
TRANSPLANTATION CHAPTER 8 ANZDATA Registry Annual Report 2013.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
Chapter 11 Paediatrics 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Paediatric.
Chapter 10 Cancer 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Cancer Working.
Final week of renal!.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 3 Mortality in End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 6 Home Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
DEATHS CHAPTER 3. © ANZDATA Registry Figure 3.1 Survival among People who Commenced Dialysis 2001—2010 (Non-Indigenous) % (95% CI) Age at Start Time Period.
STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition DEATHS CHAPTER 3.
Renal Conditions Aaqid Akram MBChB (2013) Clinical Education Fellow.
UK Renal Registry 9 th Annual Report 2006 Fig 14.1 Height Z scores for ERF patients aged 2 to 16 years in 2005.
SPECTRUM OF CHRONIC RENAL FAILURE King Hussein Medical Center Edward Saca MD, MSc.
2016 Annual Data Report, Vol 2, ESRD, Ch 8
Obesity in the end stage kidney disease population
Renal Pathology Kristine Krafts, M.D..
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
Australian Kidney Transplant Waiting List Stock and Flow
Table 1.2.1: Total number of renal biopsies by centres, 2005 – 2012
Prevalence (pmp) of Renal Replacement Therapy
Odd ratio of developing kidney failure figure 1
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Mortality rates in incident ESRD patients figure 9
Chapter 7: ESRD among Children, Adolescents, and Young Adults
UK Renal Registry 9th Annual Report 2006
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
2013 Annual Report - 36th Edition
UK Renal Registry 10th Annual Report 2007
ANZDATA Registry Annual Report 2013
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Renal Pathology Kristine Krafts, M.D..
Fig 6.1 Frequency of ischaemic heart disease in incident patients
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
Attributed cause of end-stage renal disease (ESRD) among 251 patients with SLE in the Georgia Lupus Registry who progressed to ESRD (1979–2012), overall.
Presence of inpatient diagnostic codes for attributed cause of end-stage renal disease (ESRD) among 46 patients with systemic lupus erythematosus (SLE)
Figure 3.1 Death Rates by States All Dialysis Patients
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Presentation transcript:

Chapter 1 Incidence of End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013

2014 ANZDATA Registry 37 th Annual Report Stock and Flow CountryEvent AUSTRALIA Total New Patients2431 (112)2335 (106)2511 (112)2573 (113)2544 (110) Total Transplants773 (36)846 (38)825 (37)845 (37)882 (38) - Living Donor Transplants Subsequent Transplants Total Deaths Dialysis Patients Transplant Patients Total Prevalent18510 (853)19212 (872)19909 (891)20742 (913)21470 (928) - Dialysis Patients10468 (483)10712 (486)11054 (495)11478 (505)11774 (509) - Transplant Patients8042 (371)8500 (386)8855 (396)9264 (408)9696 (419) NEW ZEALAND Total New Patients584 (136)515 (118)487 (111)517 (117)546 (123) Total Transplants121 (28)110 (25)118 (27)108 (25)115 (26) - Living Donor Transplants Subsequent Transplants Total Deaths Dialysis Patients Transplant Patients Total Prevalent3688 (857)3832 (881)3878 (885)3988 (905)4156 (936) - Dialysis Patients2281 (530)2388 (549)2392 (546)2467 (560)2584 (582) - Transplant Patients1407 (327)1444 (332)1486 (339)1521 (345)1572 (354)

2014 ANZDATA Registry 37 th Annual Report Stock and Flow by State and Country 2013 State New patients (pmp) Transplant operations(p mp) Deaths - dialysis Deaths - transplant Dialysis dependent (pmp) Functioning transplants (pmp) Total prevalent (pmp) QLD 492 (106)149 (32) (473)1879 (404)4079 (877) NSW 783 (106)288 (39) (508)2715 (366)6479 (874) ACT 53 (139)0 (0) (755)233 (611)521 (1366) VIC 651 (113)266 (46) (504)2644 (461)5536 (965) TAS 44 (86)0 (0) (421)223 (435)439 (856) SA 165 (99)81 (48) (451)970 (581)1723 (1031) NT 85 (351)0 (0) (2153)86 (355)607 (2509) WA 271 (108)98 (39) (452)946 (375)2086 (828) Aust 2544 (110)882 (38) (509)9696 (419)21470 (928) NZ 546 (123)115 (26) (582)1572 (354)4156 (936)

2014 ANZDATA Registry 37 th Annual Report

RRT Incidence (pmp) State QLD490 (113)450 (102)454 (101)473 (104)492 (106) NSW766 (109)726 (102)790 (109)811 (111)783 (106) ACT41 (116)53 (147)53 (144)63 (168)53 (139) Vic549 (102)575 (105)603 (109)634 (113)651 (113) Tas58 (115)47 (92)53 (104)49 (96)44 (86) SA207 (129)182 (112)184 (112)203 (123)165 (99) NT72 (319)65 (283)82 (355)98 (415)85 (351) WA248 (111)237 (103)292 (124)242 (99)271 (108) Aust2431 (112)2335 (106)2511 (112)2573 (113)2544 (110) NZ584 (136)515 (118)487 (111)517 (117)546 (123)

2014 ANZDATA Registry 37 th Annual Report

Incidence (pmp) of ESKD in Older Patients CountryAge Australia (234)280 (234)294 (240)317 (259)320 (258) (333)255 (281)293 (307)294 (287)316 (292) (444)291 (413)278 (382)294 (389)304 (389) (542)271 (493)301 (539)259 (452)262 (444) (394)156 (357)163 (367)189 (424)190 (425) (179)77 (199)63 (156)69 (164)59 (135) New Zealand (325)93 (402)62 (260)84 (351)77 (319) (438)70 (398)75 (416)62 (324)78 (379) (511)48 (354)47 (327)45 (298)45 (292) (472)33 (317)22 (211)27 (254)34 (311) (204)18 (227)19 (234)13 (159)8 (97) 85+4 (61)3 (44)5 (71)1 (14)4 (54)

2014 ANZDATA Registry 37 th Annual Report Age and Sex New Patients 2013 CountrySex TotalMeanMedian Australia F M , New Zealand F M

2014 ANZDATA Registry 37 th Annual Report

Late Referral by Country and Race CountryRaceLateNot lateNot reportedTotal Australia Caucasian1899 (20%)7309 (79%)82 (1%)9290 Aboriginal/TSI276 (24%)866 (74%)30 (3%)1172 Asian244 (22%)871 (78%)8 (1%)1123 Māori35 (27%)95 (73%)0 (0%)130 Pacific69 (27%)182 (72%)2 (1%)253 Other79 (22%)272 (75%)13 (4%)364 Not reported6 (10%)35 (56%)21 (34%)62 Total2608 (21%)9630 (78%)156 (1%)12394 New Zealand Caucasian169 (16%)885 (84%)4 (0%)1058 Asian29 (13%)190 (87%)0 (0%)219 Māori147 (18%)663 (81%)8 (1%)818 Pacific94 (18%)415 (81%)3 (1%)512 Other6 (18%)28 (82%)0 (0%)34 Not reported0 (0%)6 (75%)2 (25%)8 Total445 (17%)2187 (83%)17 (1%)2649

2014 ANZDATA Registry 37 th Annual Report Late Referral by Country and Disease Country Primary Renal Disease LateNot lateNot reportedTotal Australia GN590 (22%)2065 (77%)24 (1%)2679 Analgesic32 (18%)144 (81%)2 (1%)178 Polycystic69 (9%)705 (90%)11 (1%)785 Reflux43 (14%)265 (86%)1 (0%)309 Hypertension351 (21%)1351 (79%)8 (0%)1710 Diabetes792 (18%)3522 (81%)33 (1%)4347 Other540 (34%)1049 (65%)20 (1%)1609 Uncertain180 (27%)485 (72%)5 (1%)670 Not reported11 (10%)44 (41%)52 (49%)107 Total2608 (21%)9630 (78%)156 (1%)12394 New Zealand GN113 (20%)459 (80%)3 (1%)575 Analgesic4 (27%)11 (73%)0 (0%)15 Polycystic6 (4%)130 (94%)3 (2%)139 Reflux7 (15%)40 (85%)0 (0%)47 Hypertension38 (14%)231 (86%)1 (0%)270 Diabetes175 (14%)1081 (86%)7 (1%)1263 Other78 (31%)169 (68%)1 (0%)248 Uncertain22 (26%)62 (74%)0 (0%)84 Not reported2 (25%)4 (50%)2 (25%)8 Total445 (17%)2187 (83%)17 (1%)2649

2014 ANZDATA Registry 37 th Annual Report Co-morbidities of New Patients with ESKD 2013 Country Status at RRT entry Coronary artery disease Peripheral vascular disease Cerebrovascula r disease Chronic lung disease Australia No1646 (65%)1991 (78%)2258 (89%)2149 (84%) Suspected141 (6%)147 (6%)42 (2%)78 (3%) Yes757 (30%)406 (16%)244 (10%)317 (12%) New Zealand No381 (70%)438 (80%)481 (88%)465 (85%) Suspected32 (6%)23 (4%)15 (3%)22 (4%) Yes133 (24%)85 (16%)50 (9%)59 (11%)

2014 ANZDATA Registry 37 th Annual Report Smoking Status of New Patients with ESKD 2013 CountryStatus at RRT entryN (%) Australia Current288 (11%) Former1007 (40%) Never1195 (47%) Not reported54 (2%) New Zealand Current75 (14%) Former218 (40%) Never243 (45%) Not reported10 (2%)

2014 ANZDATA Registry 37 th Annual Report Diabetes Status of New Patients with ESKD 2013 CountryDiabetes at RRT entryN (%) Australia No1338 (53%) Type 1107 (4%) Type (43%) New Zealand No236 (43%) Type 120 (4%) Type 2290 (53%)

2014 ANZDATA Registry 37 th Annual Report

Primary Renal Disease of New Patients Country Primary Renal Disease Australia GN501 (21%)572 (23%)522 (20%)493 (19%) Analgesic37 (2%)33 (1%)40 (2%)26 (1%) Polycystic166 (7%)144 (6%)137 (5%)161 (6%) Reflux60 (3%)56 (2%)65 (3%)48 (2%) Hypertension321 (14%)363 (14%)321 (12%)359 (14%) Diabetes830 (36%)891 (35%)956 (37%)887 (35%) Other289 (12%)313 (12%)375 (15%)364 (14%) Uncertain131 (6%)134 (5%)129 (5%)132 (5%) Not reported0 (0%)5 (0%)28 (1%)74 (3%) Total New Zealand GN111 (22%)115 (24%)106 (21%)118 (22%) Analgesic2 (0%)5 (1%) 1 (0%) Polycystic18 (3%)29 (6%)28 (5%)30 (5%) Reflux8 (2%)9 (2%)8 (2%)13 (2%) Hypertension58 (11%)51 (10%)48 (9%)51 (9%) Diabetes260 (50%)205 (42%)252 (49%)267 (49%) Other41 (8%)52 (11%)48 (9%)53 (10%) Uncertain17 (3%)21 (4%)15 (3%)12 (2%) Not reported0 (0%) 7 (1%)1 (0%) Total

2014 ANZDATA Registry 37 th Annual Report Glomerulonephritis as Cause of Primary Renal Disease in 2013 Primary renal diseaseAustraliaNew Zealand Advanced GN (unclassified)34 Extra and intra capillary GN (rapidly progressive)60 Familial GN (including Alports)102 Focal and segmental proliferative GN1613 Focal sclerosing GN (including hyalinosis)235 GN other (specify)120 GN with systemic disease21 Goodpasture’s with linear IgG and lung haemorrhage124 Henoch-Schonlein purpura11 Membranous GN223 Mesangial proliferative (IgA+)13123 Mesangial proliferative (IgA-)102 Mesangial proliferative (no IF studies)01 Mesangiocapillary GN (double contour)102 Microscopic polyarteritis91 Presumed GN (no biopsy)12928 Primary focal sclerosing GN/focal glomerular sclerosis4713 Proliferative GN with linear IgG and no lung haemorrhage63 S.L.E.175 Scleroderma50 Secondary focal sclerosing GN33 Wegener’s granulomatosis194 Total493118

2014 ANZDATA Registry 37 th Annual Report Miscellaneous Primary Renal Diseases in 2013 Primary renal diseaseAustraliaNew Zealand Calcineurin inhibitor toxicity120 Cystinosis20 Gout10 Interstitial nephritis424 Lead nephropathy20 Lithium toxicity152 Loss of single kidney (trauma/surgery)144 Oxalosis20 Post partum nephropathy01 Pyelonephritis50 Renal tuberculosis12 Sarcoidosis20 Bladder neck obstruction (incl. prostatomegaly)30 Congenital renal hypoplasia and dysplasia282 Neuropathic bladder11 Obstructed megaureter30 Obstructive nephropathy243 Other lower urinary tract abnormalities (with secondary reflux)60 Pelvi-ureteric junction obstruction10 Posterior urethral valves70 Spina bifida or myelomeningocoele10 Ureteric obstructive nephropathy123 Calculi155 Medullary cystic disease51 Cortical necrosis43 Haemolytic uraemic syndrome92 Amyloid disease256 Light chain nephropathy (not malignant)43 Paraproteinaemia (Including Multiple Myeloma)383 Renal cell carcinoma (Grawitz)162 Transitional cell carcinoma urinary tract41 Other (Specify)605 Total36453

2014 ANZDATA Registry 37 th Annual Report